Grape King Bio Balance Sheet Health
Financial Health criteria checks 6/6
Grape King Bio has a total shareholder equity of NT$11.6B and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$15.5B and NT$3.9B respectively. Grape King Bio's EBIT is NT$2.5B making its interest coverage ratio -55.3. It has cash and short-term investments of NT$5.0B.
Key information
0%
Debt to equity ratio
NT$0
Debt
Interest coverage ratio | -55.3x |
Cash | NT$4.97b |
Equity | NT$11.63b |
Total liabilities | NT$3.88b |
Total assets | NT$15.51b |
Recent financial health updates
Here's Why Grape King Bio (TPE:1707) Can Manage Its Debt Responsibly
Mar 22Grape King Bio (TPE:1707) Seems To Use Debt Quite Sensibly
Nov 20Recent updates
Grape King Bio (TPE:1707) Knows How To Allocate Capital
Apr 06Here's Why Grape King Bio (TPE:1707) Can Manage Its Debt Responsibly
Mar 22Grape King Bio's (TPE:1707) Anemic Earnings Might Be Worse Than You Think
Mar 06How Much Did Grape King Bio's(TPE:1707) Shareholders Earn From Share Price Movements Over The Last Year?
Feb 27Grape King Bio (TPE:1707) Seems To Use Debt Quite Sensibly
Nov 20Financial Position Analysis
Short Term Liabilities: 1707's short term assets (NT$6.0B) exceed its short term liabilities (NT$3.6B).
Long Term Liabilities: 1707's short term assets (NT$6.0B) exceed its long term liabilities (NT$234.5M).
Debt to Equity History and Analysis
Debt Level: 1707 is debt free.
Reducing Debt: 1707 has no debt compared to 5 years ago when its debt to equity ratio was 16.1%.
Debt Coverage: 1707 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 1707 has no debt, therefore coverage of interest payments is not a concern.